DYNAMICS OF HISTAMINE LEVEL IN THE BLOOD PLASMA OF MALIGNANT NEOPLASM ANEMIA IN PATIENTS WITH COLORECTAL CANCER

Stanislav Vydyborets; Artem Andriiaka

doi:10.31435/rsglobal_ws/30042021/7539

Stanislav Vydyborets д.мед.н., професор, завідувач кафедри гематології і трансфузіології Національного університету охорони здоров’я України імені П.Л. Шупика, Київ, Україна https://orcid.org/0000-0003-0546-4325
Artem Andriiaka аспірант кафедри гематології і трансфузіології Національного університету охорони здоров’я України імені П.Л. Шупика, Київ, Україна https://orcid.org/0000-0003-4562-5680

DOI: https://doi.org/10.31435/rsglobal_ws/30042021/7539

Keywords: colorectal cancer, anemic syndrome, hypoxia, biogenic amines, free histamine, blood plasma

Abstract

Colorectal cancer is an extremely urgent issue in modern medicine. This disease is often complicated by anemia, which has specific pathogenetics mechanisms of development and forms a mutual burden syndrome of diseases in cancer patients. The anemic syndrome is accompanied by the development of tissue hypoxia, which in turn activates the processes of oxidative stress and leads to increased release of biologically active compounds, in particular, biogenic amines. One of these is histamine. Its high concentrations cause spasm of the arterioles, which exacerbates tissue hypoxia. We have examined (n=153) patients with colorectal cancer without anemia, (n=75) patients with colorectal cancer complicated by
malignant tumor anemia, and (n=53) patients with iron deficiency anemia. The content of plasma free serotonin fractions was determined by the fluorometric method proposed by Mikhailychenko B.V., Vydyborets S.V. (1999). The patients with iron deficiency anemia and malignant tumor anemia have shown to have a significant increase in plasma free histamine, compared with the control group and the group of patients with colorectal cancer with out anemia. Plasma free histamine was increasing together with the severity of anemia. The article discusses the feasibility of using the content of plasma free histamine, as an option, to assess the state of compensation of secondary metabolic disorders in iron deficiency anemia
and malignant tumor anemia during treatment and its possible differential diagnostic value.

References

Федоренко ЗП, Колеснік ОО, Гулак ЛО. [та співав.] Рак в Україні, 2017-2018. Захворюваність, смертність, показники діяльності онкологічної служби. Бюлетень Національного канцер-реєстру України. 20. ПП Поліум, 2019. 102.

Уніфікований клінічний протокол первинної, вторинної (спеціалізованої), третинної (високоспеціалізованої) медичної допомоги та медичної реабілітації. Колоректальний рак. Наказ Міністерства охорони здоров’я України, 12.07.2016, № 703.

Клінічна біохімія : [підручник] / за заг. ред. ГГ. Луньової. – К. : Атіка, 2013. 1156.

Михайличенко БВ, Видиборець СВ. Метод одночасного флуориметричного визначення біогенних амінів в аналізованій пробі біосубстрату. Лабораторна діагностика. 1999; 2: 58-66.

Kodama T, Takeda K, Shimozato O. [et al.] Perforin-dependent NK ctll cytotoxicity is sufficient for antimetastatic effect of IL-12. Eur. J. Immunol. 1999; 29(4): 1390 – 1396.

Robertson MJ, Williams BT, Christopherson K. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cell Immunol. 2000; 199(1): 8-14.

Gan X, Zhang L, Solomon GF, Bonavida B. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Brain, Behav and Immun. 2002; 16(3): 227 – 246.

Smart LM, Kay AB. Histamine receptors on human peripheral blood leukocytes. Clin. Exp. Immunol. 1981; 44(3): 581-586.

Kondomerkos DJ, Kalamidas SA, Kotoulas OB. In vitro effects of hormones and autacoids on the activity of acid phosphatase in the lysates of endotoxin-activated rat peritoneal and bronchoalveolar macrophages. Histol. Histopathol. 2003;18(4):1103-1113.

Nishibori M, Takahashi HK, Mori S. The regulation of ICAM-1 and LFA-1 interaction by autacoids and statins: a novel strategy for controlling inflammation and immune responses. Pharmacol. Sci. 2003;92(1): 7-12.

Garrido F, Ruiz-Cabello F, Cabrera T. [et al.]. Implications for immunosurvellance of altered HLA class I phenotypes in human tumors. Immunol. Today. 1997; 18(2): 89-95.

Jadeski LC, Lala PK. Nitric oxide syntethase inhibition by N(G)-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Amer. J. Pathol. 1999; 155(4): 1381-1390.

Harhaji L, Vuckovic O, Miljikovic D. [et al.]. Iron down-regulates macrophage antitumor activity by bloking nitric oxide production. Clin. Exp. Immunol. 2004; 137(1): 109-116.

Timoshenko AV, Lala PK, Chakraborty C. PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors. Int. J. Cancer. 2004; 108(3): 384-389.

Jang SH, Kwon YM, Chang MC. Serotonin syndrome in stroke patients. Journal of Rehabilitation Medicine. 2015; 3: 282-285.

Martin AM, Young RL, Leong L, [et al.]. The diverse metabolic roles of peripheral serotonin. Endocrinology. 2017; 5: 1049-1063.

Yabut JV, Crane JD, Green AE, [et al.]. Emerging roles for serotonin in regulating metabolism: New implications for an ancient molecule. Endocrine reviews. 2019; 4: 1092-1107.